
Sign up to save your podcasts
Or


Lisa Salberg and Dr. Marty Maron break down the latest HCM developments from ACC, including emerging myosin inhibitors, AI in imaging, and new approaches to fibrosis and genetic therapies. They also explain what these advances mean for patients now and how to prepare for a rapidly evolving treatment landscape.
This conversation was record April 10, 2026
By Hypertrophic Cardiomyopathy Association / Lisa Salberg5
88 ratings
Lisa Salberg and Dr. Marty Maron break down the latest HCM developments from ACC, including emerging myosin inhibitors, AI in imaging, and new approaches to fibrosis and genetic therapies. They also explain what these advances mean for patients now and how to prepare for a rapidly evolving treatment landscape.
This conversation was record April 10, 2026

78,688 Listeners

37,595 Listeners

12,103 Listeners

113,121 Listeners

56,944 Listeners

16,512 Listeners

47,718 Listeners